Clinical trial
ThermaChoice III Under Local Sedation in the Office Setting
NCT00420264 · Female Pelvic Medicine & Urogynecology Institute of Michigan, Other · Completed
Key facts
| NCT number | NCT00420264 |
|---|---|
| Title | ThermaChoice III Under Local Sedation in the Office Setting |
| Official title | Feasibility of Using Gynecare Thermachoice III in the Office Setting Without Conscious Sedation |
| Lead sponsor | Female Pelvic Medicine & Urogynecology Institute of Michigan, Other |
| Collaborators | Ethicon, Inc. Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heavy Uterine Bleeding |
| Intervention type | Device |
| Interventions | Uterine Ablation |
| Enrollment | 21 |
| Start date | Nov 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Jan 11, 2007 |
| Last update posted | Aug 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: